193 related articles for article (PubMed ID: 7816247)
1. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee.
Brunner FP; Selwood NH
Nephrol Dial Transplant; 1994; 9(10):1371-6. PubMed ID: 7816247
[TBL] [Abstract][Full Text] [Related]
2. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure.
McCredie M; Stewart JH; Mathew TH; Disney AP; Ford JM
Clin Nephrol; 1989 Jan; 31(1):35-9. PubMed ID: 2783667
[TBL] [Abstract][Full Text] [Related]
3. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM
Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
[TBL] [Abstract][Full Text] [Related]
4. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
[TBL] [Abstract][Full Text] [Related]
5. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
[TBL] [Abstract][Full Text] [Related]
6. Regional and social inequalities in chronic renal replacement therapy in Denmark.
Hommel K; Rasmussen S; Kamper AL; Madsen M
Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710
[TBL] [Abstract][Full Text] [Related]
7. The 2006 ERA-EDTA Registry annual report: a précis.
Stel VS; Kramer A; Zoccali C; Jager KJ
J Nephrol; 2009; 22(1):1-12. PubMed ID: 19229813
[TBL] [Abstract][Full Text] [Related]
8. The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales.
van Woerden HC; Wilkinson J; Heaven M; Merrifield J
BMC Nephrol; 2007 Jan; 8():1. PubMed ID: 17217542
[TBL] [Abstract][Full Text] [Related]
9. [Predictors of early death during dialysis].
Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
[TBL] [Abstract][Full Text] [Related]
10. Renal replacement therapy in the Canary Islands: demographic and survival analysis.
Lorenzo V; Sanchez E; Vega N; Hernandez D
J Nephrol; 2006; 19(1):97-103. PubMed ID: 16523433
[TBL] [Abstract][Full Text] [Related]
11. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
[TBL] [Abstract][Full Text] [Related]
12. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
[TBL] [Abstract][Full Text] [Related]
13. [Congenital and genetic related causes of end-stage renal disease--data from Polish Registry of Renal Rreplacement Therapy in Children 2000-2004].
Zurowska A; Zagozdzon I; Bałasz I; Boguszewska A; Prokurat C; Pietrzyk J; Drozdz D; Szczepańska M; Stefaniak E; Jander A; Roszkowska-Blaim D; Ziółkowska H; Makulska I; Kołłataj B; Jarmoliński T; Siteń G; Stankiewicz R; Wierciński R
Przegl Lek; 2006; 63 Suppl 3():57-9. PubMed ID: 16898489
[TBL] [Abstract][Full Text] [Related]
14. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies].
Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F
An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535
[TBL] [Abstract][Full Text] [Related]
15. Declining incidence of analgesic nephropathy in Canada.
Wilson DR; Gault MH
Can Med Assoc J; 1982 Sep; 127(6):500-2. PubMed ID: 7116267
[TBL] [Abstract][Full Text] [Related]
16. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
17. Trends in incidence of end-stage renal failure in Australia, 1972-1991.
Stewart JH; McCredie M; Disney AP; Mathew TH
Nephrol Dial Transplant; 1994; 9(10):1377-82. PubMed ID: 7816248
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic Nephropathy Network of Europe.
Elseviers MM; Waller I; Nenoy D; Levora J; Matousovic K; Tanquerel T; Pommer W; Schwarz A; Keller E; Thieler H
Nephrol Dial Transplant; 1995; 10(6):808-14. PubMed ID: 7566608
[TBL] [Abstract][Full Text] [Related]
19. End-stage renal disease and its treatment in Latin America in the twenty-first century.
Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
[TBL] [Abstract][Full Text] [Related]
20. The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy.
Geddes CC; van Dijk PC; McArthur S; Metcalfe W; Jager KJ; Zwinderman AH; Mooney M; Fox JG; Simpson K
Nephrol Dial Transplant; 2006 Apr; 21(4):945-56. PubMed ID: 16339161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
